Latest Articles
AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in cancer treatment - IBTimes India
AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in cancer treatment IBTimes India
Published: Feb. 10, 2026, 11:57 a.m.
AstraZeneca Pharma India Receives CDSCO Approval for Imfinzi Cancer Treatment - scanx.trade
AstraZeneca Pharma India Receives CDSCO Approval for Imfinzi Cancer Treatment scanx.trade
Published: Feb. 10, 2026, 10:22 a.m.
AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in cancer treatment - IANS LIVE
AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in cancer treatment IANS LIVE
Published: Feb. 10, 2026, 10:07 a.m.
AstraZeneca Shares Surge 3% on CDSCO Approval for Cancer Drug - Equitypandit
AstraZeneca Shares Surge 3% on CDSCO Approval for Cancer Drug Equitypandit
Published: Feb. 10, 2026, 9:36 a.m.
AstraZeneca Imfinzi Approved in India for Endometrial Cancer - Rediff MoneyWiz
AstraZeneca Imfinzi Approved in India for Endometrial Cancer Rediff MoneyWiz
Published: Feb. 10, 2026, 8:42 a.m.
AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in endometrial cancer - Express Pharma
AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in endometrial cancer Express Pharma
Published: Feb. 10, 2026, 6:40 a.m.
Endometriosis care needs a comprehensive approach - thehindu.com
Endometriosis care needs a comprehensive approach thehindu.com
Published: Feb. 9, 2026, 7:04 p.m.
Amazon's early Presidents' Day deals include discounts on Apple, Roborock, and more - Mashable
Amazon's early Presidents' Day deals include discounts on Apple, Roborock, and more Mashable
Published: Feb. 9, 2026, 6:11 p.m.
Mind the gap: underreporting of key compartments in endometriosis MRI with free-text and non-disease-specific templates.
To evaluate the impact of different reporting approaches on the completeness of endometriosis documentation in pelvic MRI reports.
Published: Feb. 9, 2026, midnight
H2S-Releasing Aspirin Nanoparticles Alleviate Endometriosis and Associated Anxiety.
Despite ongoing challenges in developing effective non-surgical and non-hormonal treatments for endometriosis, the psychological manifestations of the disease-particularly anxiety-remain comparatively underexplored. In this study, a hydrogen sulfide (H2S)-releasing aspirin derivative, …
Published: Feb. 8, 2026, midnight
Link copied to clipboard!